Mefoxin and Breastfeeding
Studies have shown that Mefoxin (cefoxitin) does pass through human breast milk. However, it passes through in such low amounts that it is not usually worth the hassle or the possibility of compromising the mother's breast milk supply to temporarily stop breastfeeding while using Mefoxin. Women who are receiving this drug while nursing should watch for thrush, diarrhea, or other problems in their infant.
Can Breastfeeding Women Receive Mefoxin?Mefoxin® (cefoxitin) passes through breast milk in humans. While Mefoxin is usually considered compatible with breastfeeding, there are some precautions to consider. Therefore, if you are nursing, talk with your healthcare provider before receiving this medicine.
More Information on Mefoxin and BreastfeedingResearch has demonstrated that Mefoxin passes through breast milk in low amounts. This low amount appears to be safe for infants. However, it is possible that an infant who is exposed to Mefoxin through breast milk might be at risk for thrush or for digestive upset, such as nausea or diarrhea. Mothers who receive Mefoxin while breastfeeding should be watchful for these potential problems.
In many situations, the potential risks are so small that it is not worth the hassle or the possibility of compromising the mother's breast milk supply to temporarily stop breastfeeding while using Mefoxin.
Mefoxin is sometimes given during a cesarean section (C-section), right after the cord is clamped, to help prevent surgical infection. In such a situation, the infant would be exposed to a very small amount of the drug through breast milk, although it is likely too little to be of concern.
Talking With Your Healthcare ProviderYou should discuss breastfeeding and Mefoxin use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.